Document is current

Article History

Received: 12 June 2023

Accepted: 15 March 2024

First Online: 2 April 2024

Declarations

:

: The study was conducted following the ethical principles of the Declaration of Helsinki and the local regulation, including privacy laws. The protocol was classified by the Agency of Medicines and Medical Devices (AEMPS) as an observational study and approved by the Ethics Committee of the Hospital Clinic of Barcelona (HCB/2022/1286). Informed consent to participate was waived by the same ethics committee that approved the study (Ethics Committee of Hospital Clinic of Barcelona).

: Not applicable.

: JP has received in the last 3 years, honoraria as a consultant and speaker from Abbvie, Eli Lilly, Novartis, Pfizer and Teva Pharmaceuticals. PPR has received in the last 3 years, honoraria as a consultant and speaker from Abbvie, Amgen, Biohaven, Chiesi, Eli Lilly, Lundbeck, Medscape, Novartis, Pfizer and Teva Pharmaceuticals. Her research group has received research grants from Instituto Salud Carlos III, EraNet Neuron, AbbVie, Novartis, Teva Pharmaceuticals, AGAUR, FEDER RIS3CAT, and has received funding for clinical trials from Abbvie, Amgen, Biohaven, Eli Lilly, Lundbeck, Novartis, and Teva Pharmaceuticals. BA and CMA are Pfizer employees. AM and MC are IQVIA employees.